APIDRA 100IU/ML INJECTION

APIDRA 100IU/ml Injection contains insulin glulisine, a rapid-acting insulin used to control high blood sugar in people with type 1 and type 2 diabetes mellitus. It starts working quickly after injection, helping manage blood glucose spikes that occur after meals. Proper glucose control reduces the risk of serious complications such as kidney damage, nerve problems, heart disease, and vision loss.

This insulin is usually used along with a long-acting insulin or other diabetes medicines as part of a complete diabetes management plan that includes diet control and regular exercise. APIDRA helps improve overall glycemic control, keeps blood sugar stable, and supports better long-term health. It is suitable for adults and children as advised by a healthcare professional.

APIDRA 100IU/ml Injection is given as a subcutaneous injection before or shortly after meals under medical guidance. Dosage depends on blood sugar levels, diet, and individual needs. Common side effects may include low blood sugar (hypoglycemia), injection site reactions, or mild weight gain. Patients should monitor glucose regularly and inform their doctor about other medicines or medical conditions before use.

Product Features

• Contains Insulin Glulisine 100 IU/ml
• Rapid-acting insulin for post-meal sugar control
• Helps manage type 1 and type 2 diabetes
• Improves overall blood glucose stability
• Used under a doctor’s supervision

How It Helps

• Quickly lowers high blood sugar after meals
• Maintains stable glucose levels
• Reduces risk of diabetes complications
• Supports long-term diabetes management